Orthopedic Disorders is Propelling the Growth of the Digital Biomarkers Market in the APAC Region!

The Asia Pacific region has been witnessing significant growth in the adoption of digital biomarkers, driven by factors such as the increasing prevalence of chronic diseases, rising healthcare expenditure, growing awareness of wearable health monitoring devices, and advancements in digital health technologies. For instance, 6.9 million people with chronic musculoskeletal conditions which accounts for 27% of the Australian population. The increasing awareness of the importance of self-monitoring and preventative healthcare, as well as the growing availability of mobile devices and the increasing prevalence of chronic diseases, are driving the growth of the digital biomarkers market in this region.

Access sample report (including graphs, charts, and figures) – https://univdatos.com/get-a-free-sample-form-php/?product_id=45819

Further, the Asia-Pacific Digital Biomarkers Market is expected to grow at a strong CAGR of 22% during the forecast period (2022-2030). The increasing healthcare expenditure in the region is the major reason for the market growth of digital biomarkers in the Asia-Pacific.

FIG. 1 APAC Digital Biomarkers Market Revenue (2020-2030)- USD Mn

Based on type, the market is segmented into wearable, mobile-based applications, sensors, and others. As per our analysis, the wearable segment held a dominant share in 2022. These devices are becoming increasingly popular as they offer a non-invasive and convenient way to monitor health and can be used for a wide range of applications, including fitness tracking, disease diagnosis, and mental health monitoring. Due to these advantages offered by the wearable segment has dominating share in the digital biomarkers market.

Based on the therapeutic area, the market is segmented into cardiovascular and metabolic disorders (CVMD), respiratory disorders, psychiatric disorders, sleep & movement disease, neurological disorders, musculoskeletal disorders, and others. The cardiovascular and metabolic disorders segment is expected to grow with a higher CAGR in the digital biomarkers market during the forecast period. The growth of the cardiovascular and metabolic disorders segment is being driven by the increasing demand for non-invasive and remote monitoring solutions, the growing awareness of the importance of self-monitoring and preventative healthcare, and the development of advanced digital biomarkers that can provide accurate and reliable data.

Based on end-use, the market is segmented into healthcare companies, healthcare providers, payers, and others. As per our analysis, the healthcare providers segment held a dominant share in 2022. The growth of the healthcare providers segment is being driven by the increasing adoption of digital health technologies, the growing demand for remote monitoring solutions, and the need for more efficient and cost-effective healthcare.

For a detailed analysis of Global Digital Biomarkers Market browse through – https://univdatos.com/report/digital-biomarkers-market/

Global Digital Biomarkers Market Segmentation

Market Insight, by Type

· Wearable

· Mobile based Applications

· Sensors

· Others

Market Insight, by Therapeutic Area

· Cardiovascular and metabolic disorders (CVMD)

· Respiratory disorders

· Psychiatric disorders

· Sleep & Movement Disease

· Neurological disorders

· Musculoskeletal disorders

· Others

Market Insight, by End-Use

· Healthcare companies

· Healthcare Providers

· Payers

· Others

Market Insight, by Region

· North America

o U.S.

o Canada

o Rest of North America

· Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe

· APAC

o China

o Japan

o India

o Rest of APAC

· Rest of the World

Top Company Profiles

· ActiGraph, LLC

· AliveCor, Inc.

· Koneksa Health

· ALTOIDA

· Amgen Inc

· Biogen

· VivoSense

· IXICO plc

· Adherium

· Neurotrack Technologies, Inc.